348 related articles for article (PubMed ID: 20130121)
1. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin protects against podocyte apoptosis in vitro.
Cormack-Aboud FC; Brinkkoetter PT; Pippin JW; Shankland SJ; Durvasula RV
Nephrol Dial Transplant; 2009 Feb; 24(2):404-12. PubMed ID: 18820279
[TBL] [Abstract][Full Text] [Related]
3. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
6. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
[No Abstract] [Full Text] [Related]
7. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin.
Li F; Mao X; Zhuang Q; Zhao Z; Zhang Z; Wu H
Cell Death Dis; 2019 Mar; 10(3):241. PubMed ID: 30858353
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
11. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
13. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
[TBL] [Abstract][Full Text] [Related]
14. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
15. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
17. Role of C/EBP-α in Adriamycin-induced podocyte injury.
Zhong F; Wang W; Lee K; He JC; Chen N
Sci Rep; 2016 Sep; 6():33520. PubMed ID: 27644413
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stretch induces podocyte hypertrophy in vitro.
Petermann AT; Pippin J; Durvasula R; Pichler R; Hiromura K; Monkawa T; Couser WG; Shankland SJ
Kidney Int; 2005 Jan; 67(1):157-66. PubMed ID: 15610239
[TBL] [Abstract][Full Text] [Related]
20. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
